Medicine and Dentistry
Toxicity
100%
Tissue Injury
100%
Anticarcinogen
100%
Programmed Cell Death
66%
Therapeutic Procedure
50%
Patient
33%
Lancovutide
33%
Technetium-99
33%
Chemotherapeutic Agent
33%
Drug
33%
Tissues
33%
Development
33%
Organ
33%
Imaging Agent
16%
Antiinfective Agent
16%
Whole Body Imaging
16%
Whole Body Scintiscanning
16%
Tumor Cell
16%
Clearance
16%
Antibody
16%
Phosphatidylethanolamine
16%
Binding Affinity
16%
Adverse Event
16%
Peptide
16%
Doxorubicin
16%
Drug Tolerance
16%
Radiopharmaceutical Agent
16%
Toxin
16%
Motivation
16%
Base
16%
Cells
16%
Oncology
16%
Indicator
16%
Evaluation Study
16%
Diagnosis
16%
Drug Combination
16%
INIS
tissues
100%
toxicity
100%
injuries
100%
antineoplastic drugs
100%
drugs
83%
apoptosis
66%
organs
33%
patients
33%
technetium 99
33%
tolerance
33%
doses
16%
information
16%
indicators
16%
specificity
16%
doxorubicin
16%
pharmaceuticals
16%
therapy
16%
tumor cells
16%
hypothesis
16%
toxins
16%
kinetics
16%
surveys
16%
optimization
16%
antibodies
16%
affinity
16%
evaluation
16%
applications
16%
peptides
16%
sensitivity
16%
ceilings
16%
clearance
16%
radiopharmaceuticals
16%
Pharmacology, Toxicology and Pharmaceutical Science
Toxicity
100%
Tissue Injury
100%
Anticarcinogen
100%
Apoptosis
50%
Technetium 99m
33%
Lancovutide
33%
Drug
33%
Adverse Event
16%
Doxorubicin
16%
Toxin
16%
Antiinfective Agent
16%
Peptide
16%
Antibody
16%
Phosphatidylethanolamine
16%
Radiopharmaceutical Agent
16%
Base
16%
Indicator
16%
Drug Tolerability
16%
Neoplasm
16%
Cell Death
16%